neuroLytixs

Brain Health For The Next Generation

Toronto, Canada · Founded 2020 · $1.1M raised

Headquarters
Toronto
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$1.1M
Last Round
$1.1M Venture Round
Rounds
1

About

neuroLytixs is a Canadian biotech and medical technology company developing AI-powered blood-based diagnostic tests for concussion detection in youth and amateur sports. Their proprietary test leverages artificial intelligence to analyze blood metabolites and lipids, achieving up to 96% accuracy in diagnosing concussions within 48 hours. Founded by CEO Peter George, CFO Adrian Uthay, and Chief Medical Officer Dr. Douglas Fraser at Western University, the company aims to revolutionize concussion diagnosis and return-to-play decision-making in organized sports.

Summary

neuroLytixs is an Artificial Intelligence company based in Toronto, Canada, founded in 2020. It has raised $1.1M in total across 1 round. Investors include Techstars.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture Round
$1.1M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

neuroLytixs on Indexed.vc
<a href="https://indexed.vc/companies/neurolytixs"><img src="https://indexed.vc/api/badge/company/neurolytixs" alt="neuroLytixs on Indexed.vc" width="260" height="76" /></a>